MMA
MDT icon

Miracle Mile Advisors’s Medtronic MDT Stock Holding History

Miracle Mile Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.14M Sell
13,156
-16,173
-55% -$1.55M 0.02% 398
2025
Q4 		$2.82M Buy
29,329
+633
+2% +$61.5K 0.04% 259
2025
Q3 		$2.73M Buy
28,696
+565
+2% +$51.9K 0.04% 260
2025
Q2 		$2.45M Buy
28,131
+388
+1% +$32.9K 0.04% 233
2025
Q1 		$2.49M Buy
27,743
+812
+3% +$72.7K 0.05% 196
2024
Q4 		$2.15M Sell
26,931
-235
-0.9% -$20.3K 0.04% 221
2024
Q3 		$2.45M Sell
27,166
-1,113
-4% -$93.6K 0.06% 167
2024
Q2 		$2.23M Sell
28,279
-335
-1% -$27.5K 0.05% 178
2024
Q1 		$2.49M Sell
28,614
-332
-1% -$28.3K 0.06% 165
2023
Q4 		$2.38M Sell
28,946
-59,735
-67% -$4.55M 0.07% 158
2023
Q3 		$6.95M Buy
88,681
+542
+0.6% +$45.4K 0.21% 87
2023
Q2 		$7.77M Buy
88,139
+201
+0.2% +$17.3K 0.24% 84
2023
Q1 		$7.09M Buy
87,938
+104
+0.1% +$8.48K 0.23% 86
2022
Q4 		$6.83M Sell
87,834
-716
-0.8% -$58K 0.23% 86
2022
Q3 		$7.15M Sell
88,550
-8,766
-9% -$788K 0.33% 59
2022
Q2 		$8.73M Buy
97,316
+51,136
+111% +$5.18M 0.41% 54
2022
Q1 		$5.12M Sell
46,180
-3,175
-6% -$335K 0.22% 79
2021
Q4 		$5.11M Buy
49,355
+1,977
+4% +$229K 0.2% 97
2021
Q3 		$5.94M Buy
47,378
+6,342
+15% +$821K 0.29% 77
2021
Q2 		$5.09M Sell
41,036
-1,758
-4% -$221K 0.27% 74
2021
Q1 		$5.05M Sell
42,794
-1,480
-3% -$173K 0.29% 70
2020
Q4 		$5.19M Buy
44,274
+5,816
+15% +$640K 0.32% 70
2020
Q3 		$4M Buy
38,458
+2,829
+8% +$284K 0.28% 77
2020
Q2 		$3.27M Sell
35,629
-161
-0.4% -$15.4K 0.27% 82
2020
Q1 		$3.23M Sell
35,790
-2,400
-6% -$255K 0.35% 54
2019
Q4 		$4.33M Buy
38,190
+1,854
+5% +$203K 0.3% 70
2019
Q3 		$3.95M Buy
36,336
+25,862
+247% +$2.7M 0.28% 78
2019
Q2 		$1.02M Buy
+10,474
New +$956K 0.08% 152

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Miracle Mile Advisors's MDT Position: Q1 2026 in Review

Miracle Mile Advisors reduced its Medtronic (MDT) stake by 55% in Q1 2026, selling an estimated $1.55M and leaving 13,156 shares worth $1.14M. The position accounts for 0.02% of the portfolio, ranked #398.

Miracle Mile Advisors first reported a position in MDT in Q2 2019 and has held it in 28 quarters since. The position peaked at $8.73M in Q2 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Miracle Mile Advisors held 13,156 shares of Medtronic worth $1.14M as of Q1 2026.
  • Miracle Mile Advisors sold 16,173 Medtronic shares in Q1 2026, an estimated $1.55M.
  • Medtronic made up 0.02% of Miracle Mile Advisors's portfolio in Q1 2026, its #398 holding.
  • Miracle Mile Advisors first reported a position in Medtronic in Q2 2019 and has held it in 28 quarters since.
  • Miracle Mile Advisors's Medtronic position peaked at $8.73M in Q2 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Miracle Mile Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.